Do you acknowledge that reliance on China for medical supplies as described in the CRS report is a concern for the united states and other nations? What structural vulnerabilities and fragile interdependencies did the COVID pandermic outbreak show in global medical supply chains? Explain your position here.

In addition, can you see similar trends in other global supply chains struggling to deal with other product categories? What solutions do you believe are needed to fix these "issues?" Are your approach more public-policy-oriented or more business-focused solutions based on the Industry 4.0 plan?

Please include citations at the end of your answers.